INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $0 | – | 740 | -3.3% | 0.00% | – |
Q3 2019 | $0 | – | 765 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 765 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $4,000 | +33.3% | 765 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $3,000 | -62.5% | 765 | 0.0% | 0.00% | -66.7% |
Q3 2018 | $8,000 | +33.3% | 765 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $6,000 | +50.0% | 765 | +3.4% | 0.00% | 0.0% |
Q1 2018 | $4,000 | -42.9% | 740 | 0.0% | 0.00% | -33.3% |
Q4 2017 | $7,000 | 0.0% | 740 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $7,000 | -22.2% | 740 | 0.0% | 0.00% | -25.0% |
Q2 2017 | $9,000 | +12.5% | 740 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $8,000 | +14.3% | 740 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $7,000 | -22.2% | 740 | 0.0% | 0.00% | -20.0% |
Q3 2016 | $9,000 | – | 740 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
GAM Holding AG | 83,940 | $808,000 | 0.02% |
SFMG, LLC | 11,994 | $115,000 | 0.02% |
SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |